State Street’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.06M Buy
1,239,337
+94,032
+8% +$232K ﹤0.01% 3155
2025
Q1
$2.28M Sell
1,145,305
-8,876
-0.8% -$17.7K ﹤0.01% 3193
2024
Q4
$3.37M Buy
1,154,181
+7,232
+0.6% +$21.1K ﹤0.01% 3123
2024
Q3
$4.44M Buy
1,146,949
+43,086
+4% +$167K ﹤0.01% 3020
2024
Q2
$5.67M Buy
1,103,863
+325,081
+42% +$1.67M ﹤0.01% 2866
2024
Q1
$5.45M Buy
778,782
+19,024
+3% +$133K ﹤0.01% 2891
2023
Q4
$6.73M Sell
759,758
-926,243
-55% -$8.21M ﹤0.01% 2792
2023
Q3
$16.1M Buy
1,686,001
+1,080,802
+179% +$10.3M ﹤0.01% 2302
2023
Q2
$8.87M Buy
605,199
+415,771
+219% +$6.09M ﹤0.01% 2706
2023
Q1
$2.33M Buy
189,428
+74,582
+65% +$917K ﹤0.01% 3293
2022
Q4
$2.13M Buy
+114,846
New +$2.13M ﹤0.01% 3353